Background Many patients with coronavirus disease 2019 (COVID-19) suffer multiple organ
dysfunctions. However, whether patients develop dyslipidemia is unknown. Objective In this …

Background COVID-19 patients develop hypolipidemia. However, it is unknown whether
lipid levels have improved and there are potential sequlae in recovered patients. Objective …

Background COVID-19 infection is epidemic worldwide. We describe the serum lipid profile
of the patients with COVID-19 infection. Methods In this retrospective study, we collected the …

Background The purpose of the study is to describe the blood lipid levels of patients
diagnosed with coronavirus disease 2019 (COVID-19) and to analyze the correlation …

Background The pandemic of coronavirus disease 2019 (COVID-19) has become a global
threat to public health. The lipid pathophysiology in COVID-19 is unknown. Methods In this …

Coronavirus disease 2019 (COVID-19) has become a global public health crisis. Reduced
low-density lipoprotein cholesterol (LDL-C) levels were observed in COVID-19 patients. The …

Lipids are indispensable in the SARS-CoV-2 infection process. The clinical significance of
plasma lipid profile during COVID-19 has not been rigorously evaluated. We aim to …

Numerous studies have observed a decrease in total cholesterol, LDL-C, HDL-C, and
apolipoprotein B and AI levels in patients with COVID-19 infections, similar to what is …

Background: Emerging studies have described and analyzed epidemiological, clinical,
laboratory, and radiological features of COVID-19 patients. Yet, scarce information is …

It is well recognized that gram positive and negative bacterial infections, tuberculosis, fungal
infections, and parasitic infections result in changes in plasma lipid levels (1–12). Of note …